CLINICAL_TRIALS
trial_result
· 2014-05-15
Clinical Trial Update: Salvage Docetaxel for Pretreated Urothelial Cancer [Phase 2]
Summary
This report provides an update on a Phase 2 trial evaluating salvage docetaxel in patients with pretreated bladder cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Samsung Medical Center | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED